Corrigendum to "The effects of splicing variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA expressions" [Clinica Chima Acta 403 (2009) 142-144] (DOI:10.1016/j.cca.2009.02.006);The effects of splicing variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA expressions

Clinica Chimica Acta

Volumn 403, Issue 1-2, 2009, Pages 142-144

  Liu, Yan ^a   Ji, Wei ^a,c   Yin, You ^b   Fan, Lan ^a   Zhang, Jian ^c   Yun, Huang ^d   Wang, Nianci ^a   li, Qing ^a   Wei, Zhang ^a   Ouyang, Dongshen ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

6bp deletion; Alternative splicing; CYP3A4; MDR1; PAR 2(SV1); PXR

Indexed keywords

CYTOCHROME P450 3A4; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PREGNANE X RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2;

ADULT; AGED; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 64849101644     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.002     Document Type: Erratum

References (14)

1. Sueyoshi T., and Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41 (2001) 123-143
2. Sugatani J., Kojima H., Ueda A., et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyl transferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33 5 (2001) 1232-1238
3. Sonoda J., Xie W., Rosenfeld J., et al. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 99 21 (2002) 13801-13806
4. Synold T.W., Dussault I., and Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7 5 (2001) 584-590
5. Owen A., Chandler B., Back D.J., et al. Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA Antiviral Therapy vol. 9(5) (2004) 819-821
6. Carnahan V.E., and Redinbo M.R. Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab 6 (2005) 357-367
7. Lamba J., Lamba V., and Schuetza E. Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics. Curr Drug Metab 6 (2004) 369-383
8. Koyano S., Kurose K., Saito Y., et al. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. DMD 32 (2004) 149-154
9. Blencowe B.J. Alternative splicing: new insights from global analyses. Cell 126 (July 14 2006)
10. Kurose K., Koyano S., Ikeda S., Tohkin M., Hasegawa R., and Sawada J.-I. 5′ Diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site. Mol Cell Biochem 273 (2005) 79-85
11. Xing Y., and Lee C. Alternative splicing and RNA selection pressure evolutionary consequences for eukaryotic genomes. Genetics 7 (2006) 499
12. Fukuen S., Fukuda T., Matsuda H., et al. Identification of the novel splicing variants for the hPXR in human livers. Biochem Biophys Res Commun 298 (2002) 433-438
13. Lamba V., Yasuda K., Lamba J.K., et al. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 199 (2004) 251-265
14. Uno Y., Sakamoto Y., Yoshida K., et al. Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter. J Hum Genet 48 11 (2003) 594-597